Загрузка...
Advances in delivery systems for doxorubicin
Doxorubicin is a widely used chemotherapy agent. Despite its utility, several adverse side effects, especially its irreversible cardiotoxicity and reversible nephrotoxicity, have prompted the development of liposomal carriers, many of which are FDA approved. Antitumor efficacies of approved liposome...
Сохранить в:
| Опубликовано в: : | J Nanomed Nanotechnol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6319900/ https://ncbi.nlm.nih.gov/pubmed/30613436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2157-7439.1000519 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|